Cyclin D, encoded by the CCND1 gene, has already given rise to a class of widely used breast cancer drugs known as CDK4/6 inhibitors. Compared with targeting cyclin D and CDK4/6, which are ...

BACKGROUND: In recent years, numerous studies have been performed to investigate the CCND1 G870A gene polymorphism impact on brain tumors susceptibility. Unfortunately, the results of previous ...